drugset / Trial / NCT00683657
Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone
RandomizedParallel-groupDouble-blindTreatment
Summary
This protocol will compare 24 hour glucose control for subject taking saxagliptin and metformin extended release (XR) versus metformin XR alone
Timeline
- Start
- 2008-07
- Primary completion
- 2009-02
- Completion
- 2009-02
Outcome
Met primary endpoint
registry Saxagliptin 5 mg + Metformin vs Placebo + Metformin; p = 0.0001; Mean Difference (Final Values) -16.8 (95% CI -25.1 to -8.5) NCT00683657 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAXAGLIPTIN ANHYDROUS | Small molecule | 5 mg | Oral |